Top Markets
Coin of the day
BioSig Technologies, Inc. BioSig Technologies, Inc.

BioSig Technologies, Inc.

BSGM
Rangering i aksjer #10875
BioSig Technologies, Inc., along with its subsidiaries, operates as a medical... BioSig Technologies, Inc., along with its subsidiaries, operates as a medical technology enterprise. Its core innovation is the PURE EP (precise uninterrupted real-time evaluation of electrograms electrophysiology) system. This proprietary signal processing platform, merging specialized hardware and software, tackles well-known difficulties in electrophysiological signal acquisition, empowering electrophysiologists to instantaneously view and analyze vital cardiac signals. The system further enhances the collection of intracardiac signals and diagnostic data crucial for atrial fibrillation procedures. Moreover, it is specifically engineered to overcome persistent obstacles that traditionally slow down and complicate cardiac catheter ablation. BioSig also holds a research agreement with the University of Minnesota, targeting the development of new treatments for sympathetic nervous system disorders. Additionally, it has a strategic partnership with the Mayo Foundation for Medical Education and Research, focused on creating an advanced AI and machine learning software solution tailored for its PURE EP platforms. Established in 2009, BioSig Technologies, Inc. is headquartered in Westport, Connecticut.
Aksjekurs
$5.52
Sist synkronisert: 2025-10-09
Markedsverdi
$775.10M
Endring (1 dag)
1.28%
Endring (1 år)
15.48%
Land
US
Handel BioSig Technologies, Inc. (BSGM)

Kategori

P/E-forhold for BioSig Technologies, Inc. (BSGM)
P/E-forhold per August 2026 TTM: -4.96
Ifølge BioSig Technologies, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) -4.96. Ved slutten av 2023 hadde selskapet en P/E på -12.02.
P/E-forholdshistorikk for BioSig Technologies, Inc. fra 2011 til 2026
P/E-forhold ved slutten av hvert år
År P/E-forhold Endre
2026 (TTM) -4.96 -75.51%
2024 -20.25 68.43%
2023 -12.02 81.27%
2022 -6.63 -72.16%
2021 -23.83 14.23%
2020 -20.86 -42.24%
2019 -36.12 0.60%
2018 -35.90 23.88%
2017 -28.98 33.56%
2016 -21.70 12.40%
2015 -19.31 -39.46%
2014 -31.89 18.97%
2013 -26.81 -97.46%
2012 -1.06K -53.54%
2011 -2.27K 0.00%
P/E-forhold for lignende selskaper eller konkurrenter
Selskap P/E-forhold Forskjell i P/E-forhold Land
35.77 -821.37%
US
34.86 -802.97%
US
21.39 -531.27%
IE
20.90 -521.41%
US
- -
DE
Hvordan lese en P/E-ratio?

Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.

Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.

Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.